Has Michael Osman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,349 in general payments to Michael Osman, MD across 101 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Osman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Osman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Osman, MD

Retina Specialist · Sterling, VANPI 1821062803

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.8% — the pattern of someone who eats at a lot of different presentations.

$3,349in general payments, 2019–2025

Across 101 payments — averaging $33.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$596
Regeneron Healthcare Solutions, Inc.$539
Apellis Pharmaceuticals, Inc.$315
Genentech USA, Inc.$297
Astellas Pharma US Inc$252
Alcon$235
plus $1K from 12 others

What the payments were for

Food & beverage$3,349100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	23	$596
Regeneron Healthcare Solutions, Inc.	18	$539
Apellis Pharmaceuticals, Inc.	8	$315
Genentech USA, Inc.	13	$297
Astellas Pharma US Inc	6	$252
Alcon	2	$235
Rxsight Inc	2	$151
ANI Pharmaceuticals, Inc.	2	$135
Alimera Sciences, Inc.	6	$128
Kala Pharmaceuticals, Inc.	1	$125
Dompe US, Inc.	1	$125
Bausch & Lomb Americas Inc.	6	$122
Eyepoint US, Inc.	5	$118
Sandoz	2	$58
Coherus Oncology, Inc.	2	$53
Novartis	2	$45
Genentech, Inc.	1	$36
Mallinckrodt Hospital Products Inc.	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,349 in reported general payments places this provider in the 65th percentile of 41 retina specialist providers in Virginia.

See all retina specialist providers in Virginia →

Medicare billing

Part B allowed, 2024

$5,183,788

Medicare patients

1,637

Services billed

31,910

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	96	$4,233
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol	14	$2,476
Loteprednol Etabonate	16	$2,413
Ketorolac Tromethamine	89	$1,992
Difluprednate	13	$1,273
Timolol Maleate	49	$1,033
Latanoprost	70	$662
Atropine Sulfate	18	$654
Brimonidine Tartrate	16	$638
Ofloxacin	32	$521
ErythromycinErythromycin Base	22	$192

Paid to pharmacies, not to this prescriber.

Other retina specialist in Sterling

Mohammed BaraziSterling$1K
Jordana FeinManassas$412K
Joaquin TosiVirginia Beach$48K
Mohit NandaCharlottesville$31K
Muge KesenMc Lean$30K
Anna MackinRoanoke$26K
Jon AdlebergChesapeake$21K
Dal ChunVienna$12K
Kori ElkinsPortsmouth$9K
Jiwei ShengFairfax$8K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →